)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Egetis Therapeutics
Egetis Therapeutics (EGTX) investor relations material
Egetis Therapeutics Corporate presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate presentation summary4 Mar, 2026
Strategic highlights and product development
Emcitate (tiratricol) launched in Germany in May 2025 and rolling U.S. NDA completed in January 2026.
Emcitate is the first and only approved treatment for MCT8 deficiency in the EU, with anticipated FDA decision in September 2026.
Strong regulatory status: Breakthrough Therapy and Orphan Drug Designations, with market exclusivity of 10 years in EU and 7 years in US.
Partnerships established for Japan, Türkiye, Central/Eastern Europe, and the Gulf region to optimize global access.
Expansion potential into Resistance to Thyroid Hormone Type Beta (RTH-β), with orphan drug designation for this indication.
Clinical efficacy and patient impact
Emcitate demonstrated significant and durable reduction of T3 levels, normalization of thyrotoxicosis, and improved cardiovascular health and bodyweight in MCT8 deficiency patients.
Real-world evidence shows a threefold reduction in mortality risk for patients treated with tiratricol.
European Thyroid Association recommends Emcitate as long-term therapy for all MCT8 deficiency patients.
Patient-centered outcomes include improved interaction, alertness, motor skills, and reduced sweating.
Safety profile is benign, with benefits maintained or improving over up to six years.
Commercial execution and market access
2025 revenue reached 62.4 MSEK, up 40% year-over-year; Q4 revenue up 74% year-over-year.
Phased EU launch began in Germany, with pricing and reimbursement processes advancing in major markets.
U.S. launch preparations include deep engagement in referral centers, expanded access programs, and payer strategy validation.
Lean, agile commercial team with global experience and strong KOL support.
Priority Review Voucher upon U.S. approval could yield significant financial upside.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Egetis Therapeutics earnings date
Leerink Global Healthcare Conference 202611 Mar, 2026
Egetis Therapeutics
Next Egetis Therapeutics earnings date
Leerink Global Healthcare Conference 202611 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Egetis Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of treatments for rare and severe diseases. Its portfolio includes late-stage product candidates targeting unmet medical needs. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage